Literature DB >> 25228546

Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation.

Masahiro Omoto1, Kishore R Katikireddy1, Alexandra Rezazadeh1, Thomas H Dohlman1, Sunil K Chauhan1.   

Abstract

PURPOSE: To investigate whether systemically injected syngeneic mesenchymal stem cells (MSCs) can home to the transplanted cornea, suppress induction of alloimmunity, and promote allograft survival.
METHODS: Mesenchymal stem cells were generated from bone marrow of wild-type BALB/c or GFP (green fluorescent protein)+ C57BL/6 mice, and 1×10(6) cells were intravenously injected to allografted recipients 3 hours after surgery. Mesenchymal stem cells homing to the cornea were examined at day 3 post transplantation by immunohistochemistry. MHC (major histocompatibility complex) II+CD11c+ cells were detected in the cornea and lymph nodes (LNs) 14 days post transplantation using flow cytometry. Cytokine expression of bone marrow-derived dendritic cells (BMDCs) was determined using real-time PCR. ELISPOT assay was used to assess indirect and direct host T cell allosensitization, and graft survival was evaluated by slit-lamp biomicroscopy weekly up to 8 weeks.
RESULTS: Intravenously injected GFP+ MSCs were found in abundance in the transplanted cornea, conjunctiva, and LNs, but not in the ungrafted (contralateral) tissue. The frequencies of mature MHC II+CD11c+ antigen-presenting cells (APCs) were substantially decreased in the corneas and draining LNs of MSC-injected allograft recipients compared to control recipients. Maturation and function of in vitro cultured BMDCs were decreased when cocultured with MSCs. Draining LNs of MSC-injected allograft recipients showed lower frequencies of IFNγ-secreting Th1 cells compared to the control group. Allograft survival rate was significantly higher in MSC-injected recipients compared to non-MSC-injected recipients.
CONCLUSIONS: Our data demonstrate that systemically administered MSCs specifically home to the inflamed ocular surface and promote allograft survival by inhibiting APC maturation and induction of alloreactive T cells. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  allosensitization; antigen-presenting cells; cornea transplantation; homing; mesenchymal stem cells

Mesh:

Substances:

Year:  2014        PMID: 25228546     DOI: 10.1167/iovs.14-15413

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

Review 1.  Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.

Authors:  Maryam Tahvildari; Afsaneh Amouzegar; William Foulsham; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2018-01-06       Impact factor: 9.261

Review 2.  High-risk corneal allografts: A therapeutic challenge.

Authors:  Tian Yu; Vijayalakshmi Rajendran; May Griffith; John V Forrester; Lucia Kuffová
Journal:  World J Transplant       Date:  2016-03-24

Review 3.  Strategies for reconstructing the limbal stem cell niche.

Authors:  Ghasem Yazdanpanah; Zeeshan Haq; Kai Kang; Sayena Jabbehdari; Mark L Rosenblatt; Ali R Djalilian
Journal:  Ocul Surf       Date:  2019-01-08       Impact factor: 5.033

4.  Mesenchymal Stem Cells Modulate Differentiation of Myeloid Progenitor Cells During Inflammation.

Authors:  Afsaneh Amouzegar; Sharad K Mittal; Anuradha Sahu; Srikant K Sahu; Sunil K Chauhan
Journal:  Stem Cells       Date:  2017-03-30       Impact factor: 6.277

5.  Epithelium-derived IL-33 activates mast cells to initiate neutrophil recruitment following corneal injury.

Authors:  Elsayed Elbasiony; Sharad K Mittal; William Foulsham; WonKyung Cho; Sunil K Chauhan
Journal:  Ocul Surf       Date:  2020-06-29       Impact factor: 5.033

6.  Therapeutic efficacy of different routes of mesenchymal stem cell administration in corneal injury.

Authors:  Sachin Shukla; Sharad K Mittal; William Foulsham; Elsayed Elbasiony; Disha Singhania; Srikant K Sahu; Sunil K Chauhan
Journal:  Ocul Surf       Date:  2019-07-03       Impact factor: 5.033

Review 7.  Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs.

Authors:  Darwin J Prockop; Joo Youn Oh; Ryang Hwa Lee
Journal:  Mol Ther       Date:  2017-06-22       Impact factor: 11.454

Review 8.  Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Winston W-Y Kao
Journal:  Ocul Surf       Date:  2016-01-12       Impact factor: 5.033

Review 9.  Revisiting the role of erythropoietin for treatment of ocular disorders.

Authors:  S L Shirley Ding; S N Leow; R Munisvaradass; E H Koh; M L C Bastion; K Y Then; S Kumar; P L Mok
Journal:  Eye (Lond)       Date:  2016-06-10       Impact factor: 3.775

10.  Emerging Approaches for Ocular Surface Regeneration.

Authors:  Ghasem Yazdanpanah; Sayena Jabbehdari; Ali R Djalilian
Journal:  Curr Ophthalmol Rep       Date:  2019-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.